Allergan Requests Appeal Of Del. Botox Decision

Law360, Wilmington (June 21, 2012, 10:40 PM ET) -- Allergan Inc.'s board applied on Thursday for an interlocutory appeal of a Delaware judge's game-changing decision that kept alive a shareholder derivative suit against the Botox manufacturer.

On June 11, Vice Chancellor J. Travis Laster of the Delaware Chancery Court refused to dismiss the suit, which targeted Allergan directors over alleged off-label marketing of the anti-wrinkle drug that led to a $600 million settlement with the U.S. Department of Justice.

But he did so despite a California federal court’s prior decision to throw out a parallel...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers